Arbutus Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ABUS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
03 Apr 24	BuyUS$15,961	Whitefort Capital Management, LP	Company		5,815	US$2.74

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABUS?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,557,067	0.822%
Hedge Funds	12,867,967	6.79%
Public Companies	38,847,462	20.5%
General Public	47,966,097	25.3%
Institutions	88,253,092	46.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.

Top Shareholders

Top 25 shareholders own 69.93% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.5%	Roivant Sciences Ltd.	38,847,462	US$127.0m	0%	no data
10.6%	Morgan Stanley Investment Management Inc.	20,032,417	US$65.5m	3.22%	0.05%
6.79%	Whitefort Capital Management, LP	12,867,967	US$42.1m	0%	17.05%
6.45%	BlackRock, Inc.	12,218,759	US$40.0m	5.77%	no data
4.71%	The Vanguard Group, Inc.	8,918,582	US$29.2m	27%	no data
4.43%	Two Seas Capital LP	8,387,388	US$27.4m	-2.15%	4.13%
2.33%	State Street Global Advisors, Inc.	4,407,133	US$14.4m	50.2%	no data
1.82%	Geode Capital Management, LLC	3,448,600	US$11.3m	4.09%	no data
1.57%	FourWorld Capital Management LLC	2,972,527	US$9.7m	0%	4.21%
1.53%	Adage Capital Management, L.P.	2,900,941	US$9.5m	-3.3%	0.02%
1.1%	ADAR1 Capital Management, LLC	2,089,321	US$6.8m	-36.5%	1.26%
1.09%	BlackBarn Capital Partners LP	2,070,900	US$6.8m	0%	3.1%
0.89%	Rubric Capital Management LP	1,681,090	US$5.5m	0%	0.1%
0.79%	Michael Sofia	1,487,983	US$4.9m	0%	no data
0.74%	Morgan Stanley, Investment Banking and Brokerage Investments	1,400,944	US$4.6m	9.13%	no data
0.72%	Osaic Wealth, Inc. , Asset Management Arm	1,362,454	US$4.5m	0.18%	0.01%
0.65%	Northern Trust Global Investments	1,228,442	US$4.0m	16.9%	no data
0.64%	Charles Schwab Investment Management, Inc.	1,212,246	US$4.0m	219%	no data
0.54%	Hudson Bay Capital Management LP	1,030,000	US$3.4m	-38.9%	0.03%
0.45%	Corbin Capital Partners, L.P.	853,304	US$2.8m	0%	3.01%
0.36%	Saba Capital Management, L.P.	676,427	US$2.2m	3.84%	0.05%
0.35%	Woodline Partners LP	668,153	US$2.2m	-27.9%	0.02%
0.32%	Boothbay Fund Management, LLC	612,277	US$2.0m	0%	0.06%
0.32%	Citadel Advisors LLC	607,744	US$2.0m	320%	no data
0.28%	Goldman Sachs Group, Investment Banking and Securities Investments	534,752	US$1.7m	308%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 09:35
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arbutus Biopharma Corporation is covered by 27 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Madhu Kumar	Baird
Brian Skorney	Baird
David Martin	Bloom Burton & Co.